Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Ther Drug Monit. 2018 Aug;40(4):469–476. doi: 10.1097/FTD.0000000000000516

Table 2.

Linearity, inaccuracy, and imprecision characteristics.

Intra-assay (n = 6) Inter-assay (n = 18)

Assay range (μg/mL) Linearity (R2) QC level Mean (μg/mL) Imprecision (% CV) Inaccuracy (% Dev) Mean (μg/mL) Imprecision (% CV) Inaccuracy (% Dev)

GBP 0.1–100 0.9988 LLOQ 0.110 8.22 14.3 0.120 8.91 17.8
Low 0.280 7.30 −7.89 0.310 14.9 3.65
Mid 34.0 2.16 13.2 33.4 3.77 11.4
High 91.1 5.63 7.20 89.9 4.35 5.72

LTG 0.1–100 0.9998 LLOQ 0.120 7.96 16.0 0.120 7.92 19.7
Low 0.280 4.54 −8.06 0.310 9.88 2.91
Mid 33.2 4.71 10.6 32.8 6.17 9.19
High 97.0 7.40 14.2 94.7 6.01 11.4

LEV 0.1–100 0.9992 LLOQ 0.100 13.2 0.00 0.110 17.3 13.6
Low 0.330 8.56 9.67 0.340 6.48 15.0
Mid 31.2 2.18 3.95 31.3 2.02 4.37
High 85.2 1.14 0.210 83.0 2.49 −2.40

MHD 0.1–100 0.9999 LLOQ 0.120 4.73 15.5 0.120 4.33 16.2
Low 0.330 3.75 10.2 0.330 2.82 10.7
Mid 31.2 1.44 4.07 31.2 1.66 3.95
High 89.2 2.07 4.99 89.0 1.87 4.70

ZNS 0.1–100 0.9998 LLOQ 0.120 7.50 18.3 0.120 11.1 18.4
Low 0.320 4.17 5.28 0.330 6.83 10.4
Mid 33.7 4.36 12.5 33.1 4.40 10.5
High 91.3 2.83 7.46 94.2 3.54 10.8